Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients
暂无分享,去创建一个
Javier Martín | J. Pers | L. Kovács | R. Cervera | L. Beretta | G. Barturen | M. Kerick | D. Cornec | C. Chizzolini | N. Hunzelmann | M. Gerosa | R. Lesche | E. De Langhe | Z. Makowska | I. Almeida | B. Vigone | C. Bellocchi | M. Alarcón-Riquelme | R. Ortega Castro
[1] S. Assassi,et al. Type I interferon dysregulation in Systemic Sclerosis. , 2020, Cytokine.
[2] Javier Martín,et al. Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis , 2019, Current Rheumatology Reports.
[3] B. Korman. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis. , 2019, Translational research : the journal of laboratory and clinical medicine.
[4] M. Manetti,et al. A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems. , 2019, Clinical and experimental rheumatology.
[5] J. Varga,et al. Emerging targets of disease-modifying therapy for systemic sclerosis , 2019, Nature Reviews Rheumatology.
[6] M. Bulyk,et al. The multiple mechanisms that regulate p53 activity and cell fate , 2019, Nature Reviews Molecular Cell Biology.
[7] T. Radstake,et al. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis , 2019, Front. Immunol..
[8] A. Segura‐Carretero,et al. Urinary and plasma metabolite differences detected by HPLC‐ESI‐QTOF‐MS in systemic sclerosis patients , 2019, Journal of pharmaceutical and biomedical analysis.
[9] Nir Hacohen,et al. Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures , 2019, Science Advances.
[10] S. Bhattacharyya,et al. Targeting TLRs and the inflammasome in systemic sclerosis , 2018, Pharmacology & therapeutics.
[11] Sun Kim,et al. Comprehensive and critical evaluation of individualized pathway activity measurement tools on pan-cancer data , 2018, Briefings Bioinform..
[12] S. Shetty,et al. p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling. , 2018, The American journal of pathology.
[13] I. Parra-Rojas,et al. AB0389 Hipertriglyceridemic-waist phenotype: a marker of cardiovascular risk in rheumatoid arthritis patients , 2018, Rheumatoid arthritis – comorbidity and clinical aspects.
[14] Z. Modrušan,et al. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis , 2018, Annals of the rheumatic diseases.
[15] Enrico Petretto,et al. Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk , 2018, Annals of the rheumatic diseases.
[16] Jae Cheol Lee,et al. Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis , 2018, The Journal of pathology.
[17] Fengzhi Li,et al. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer? , 2017, American journal of cancer research.
[18] J. D. de Vries-Bouwstra,et al. Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis. , 2017, The Journal of investigative dermatology.
[19] Lihua Zhang,et al. Systematic approach to understanding the pathogenesis of systemic sclerosis , 2017, Clinical genetics.
[20] A. Sawalha,et al. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. , 2017, Journal of autoimmunity.
[21] M. Manetti,et al. The “myth” of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event? , 2017, Arthritis Research & Therapy.
[22] D. Stolz,et al. Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis. , 2017, The Journal of investigative dermatology.
[23] C. Greenwood,et al. Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis , 2017, Epigenetics.
[24] M. Fujimoto,et al. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease. , 2017, The American journal of pathology.
[25] Robert W. Hoffman,et al. Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab , 2016, Arthritis & rheumatology.
[26] J. Li. Effect size measures in a two-independent-samples case with nonnormal and nonhomogeneous data , 2016, Behavior research methods.
[27] Christophe Jamin,et al. Multi-center harmonization of flow cytometers in the context of the European "PRECISESADS" project. , 2016, Autoimmunity reviews.
[28] Marta E. Alarcón-Riquelme,et al. Gene Expression and Pharmacodynamic-Induced Changes in 1 , 760 SLE Patients from Two Phase III Trials of B Cell Activating Factor Blockade with Tabalumab , 2016 .
[29] G. Krenning,et al. FGF2 inhibits endothelial–mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling , 2016, Journal of Cell Science.
[30] Daniel J. Gaffney,et al. A survey of best practices for RNA-seq data analysis , 2016, Genome Biology.
[31] Peter A. Flach,et al. Precision-Recall-Gain Curves: PR Analysis Done Right , 2015, NIPS.
[32] S. Ogawa,et al. Defects in Regulatory T Cells Due to CD28 Deficiency Induce a Qualitative Change of Allogeneic Immune Response in Chronic Graft-versus-Host Disease , 2015, The Journal of Immunology.
[33] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[34] Peipei Ping,et al. Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart Failure , 2014, PloS one.
[35] Hanspeter Pfister,et al. UpSet: Visualization of Intersecting Sets , 2014, IEEE Transactions on Visualization and Computer Graphics.
[36] M. Jinnin,et al. Serum levels of matrix metalloproteinase‐13 in patients with eosinophilic fasciitis , 2014, The Journal of dermatology.
[37] E. Donadi,et al. Patients with Systemic Sclerosis Present Increased DNA Damage Differentially Associated with DNA Repair Gene Polymorphisms , 2014, The Journal of Rheumatology.
[38] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[39] M. Mayes,et al. What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis? , 2013, Current opinion in rheumatology.
[40] Oliver Distler,et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.
[41] M. Mayes,et al. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .
[42] S. Shen-Orr,et al. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. , 2013, Current opinion in immunology.
[43] Y. Lussier,et al. Curation-free biomodules mechanisms in prostate cancer predict recurrent disease , 2013, BMC Medical Genomics.
[44] Yong Huang,et al. Single Sample Expression-Anchored Mechanisms Predict Survival in Head and Neck Cancer , 2012, PLoS Comput. Biol..
[45] R. Silver,et al. Coagulation and autoimmunity in scleroderma interstitial lung disease. , 2011, Seminars in arthritis and rheumatism.
[46] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[47] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[48] Inke R. König,et al. Validation in Genetic Association Studies , 2011, Briefings Bioinform..
[49] Kenneth G. C. Smith,et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis , 2009, Annals of the rheumatic diseases.
[50] A. Postlethwaite,et al. Platelet contributions to the pathogenesis of systemic sclerosis , 2007, Current opinion in rheumatology.
[51] S. Akira,et al. Toll-like Receptors and Type I Interferons* , 2007, Journal of Biological Chemistry.
[52] Sung-Hwan Park,et al. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis , 2004, Arthritis research & therapy.
[53] D. Shegogue,et al. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. , 2002, The Journal of investigative dermatology.
[54] L. Rudnicka,et al. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis , 2001, Arthritis research.
[55] Daniel B. Rifkin,et al. Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.
[56] A. Nanji,et al. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. , 1988, Life sciences.
[57] Xiaodong Zhou,et al. Sirtuin1 Protects against Systemic Sclerosis‐related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes , 2018, American journal of respiratory cell and molecular biology.
[58] Qiang Sun,et al. Individual-level analysis of differential expression of genes and pathways for personalized medicine , 2015, Bioinform..
[59] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[60] M. Gerstein,et al. RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.
[61] Ralph L. Rosnow,et al. Essentials of Behavioral Research: Methods and Data Analysis , 1984 .